Literature DB >> 17495626

Patent foramen ovale, stroke, and cardiovascular disease in migraine.

Hans-Christoph Diener1, Tobias Kurth, David Dodick.   

Abstract

PURPOSE OF REVIEW: We will review the literature on the association between migraine with patent foramen ovale, stroke, and coronary heart disease. RECENT
FINDINGS: The prevalence of patent foramen ovale in patients with migraine with aura is significantly higher than in nonmigraine controls and migraineurs without aura. However, there is currently no evidence to support a causal relationship. Migraine with aura has been consistently associated with increased risk of ischemic stroke in several epidemiologic studies. Migraine with aura is associated with a more unfavourable cardiovascular risk profile and recent data suggest that the association between migraine with aura and stroke may extend to overall cardiovascular disease. Identification of migraine patients at particular risk for stroke or other vascular events is impossible based on current knowledge.
SUMMARY: Migraine with aura and patent foramen ovale have higher coincidences than expected by chance only. It is possible that both conditions are inherited together. Until now there has been no evidence from placebo-controlled randomized trials that closure of patent foramen ovale improves migraine with aura. There is increasing evidence that migraine with aura is not only a risk factor for ischemic stroke but also for myocardial infarction and other ischemic vascular events.

Entities:  

Mesh:

Year:  2007        PMID: 17495626     DOI: 10.1097/WCO.0b013e328136c22d

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  11 in total

1.  Prevalence and characteristics of right-to-left shunt in migraine with aura: a survey on 120 Italian patients.

Authors:  L Caputi; Domenico D'Amico; S Usai; L Grazzi; E A Parati; G Bussone
Journal:  Neurol Sci       Date:  2009-05       Impact factor: 3.307

Review 2.  The association of migraine with ischemic stroke.

Authors:  Tobias Kurth
Journal:  Curr Neurol Neurosci Rep       Date:  2010-03       Impact factor: 5.081

Review 3.  Our evolving understanding of migraine with aura.

Authors:  Justin M DeLange; F Michael Cutrer
Journal:  Curr Pain Headache Rep       Date:  2014-10

Review 4.  The brain's heart - therapeutic opportunities for patent foramen ovale (PFO) and neurovascular disease.

Authors:  Mingming Ning; Eng H Lo; Pei-Chen Ning; Su-Yu Xu; David McMullin; Zareh Demirjian; Ignacio Inglessis; G William Dec; Igor Palacios; Ferdinando S Buonanno
Journal:  Pharmacol Ther       Date:  2013-03-23       Impact factor: 12.310

Review 5.  Migraine with and without aura and risk for cardiovascular disease.

Authors:  Bert B Vargas; David W Dodick; Dean M Wingerchuk; Bart M Demaerschalk
Journal:  Curr Atheroscler Rep       Date:  2008-10       Impact factor: 5.113

Review 6.  [Current diagnosis and treatment of migraine].

Authors:  H-C Diener; Z Katsarava; V Limmroth
Journal:  Schmerz       Date:  2008-02       Impact factor: 1.107

7.  [Headache and migraine].

Authors:  H C Diener; M A Slomke; V Limmroth
Journal:  Nervenarzt       Date:  2007-09       Impact factor: 1.214

8.  Migraine headache in middle age and late-life brain infarcts.

Authors:  Ann I Scher; Larus S Gudmundsson; Sigurdur Sigurdsson; Anna Ghambaryan; Thor Aspelund; Gudny Eiriksdottir; Mark A van Buchem; Vilmundur Gudnason; Lenore J Launer
Journal:  JAMA       Date:  2009-06-24       Impact factor: 56.272

9.  Reference programme: diagnosis and treatment of headache disorders and facial pain. Danish Headache Society, 2nd Edition, 2012.

Authors:  Lars Bendtsen; Steffen Birk; Helge Kasch; Karen Aegidius; Per Schmidt Sørensen; Lise Lykke Thomsen; Lars Poulsen; Mary-Jette Rasmussen; Christina Kruuse; Rigmor Jensen
Journal:  J Headache Pain       Date:  2012-02       Impact factor: 7.277

10.  No evidence of jugular venous valve insufficiency in patients with migraine--a controlled study.

Authors:  Kasja Rabe; Michael Küper; Dagny Holle; Irini Savidou; Oliver Kastrup; Andreas Jähne-Blasberg; Hans Christoph Diener; Zaza Katsarava; Markus Frings
Journal:  J Headache Pain       Date:  2013-06-19       Impact factor: 7.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.